METHOCEL™ Premium CR Cellulose Ethers


First choice for the formulation of hydrophilic matrix systems, providing a robust mechanism for the extended/controlled release of drugs from oral solid dosage forms. With a choice of viscosity grades METHOCEL™ premium cellulose ethers provide a simple solution to meet a range of drug solubility needs. Tablets are easily manufactured with existing, conventional equipment and processing methods.


Matrix Tablet Formulations


Product Literature

METHOCEL™ is a trademark of The Dow Chemical Company